Shares of Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) got a boost, shooting 130% to $5.59 after the company announced the acquisition of Quellis Biosciences.
GameStop Corp. (NYSE: GME) shares were also up, gaining 74% to $337.03 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday.
Equities Trading DOWN
Drive Shack Inc. (NASDAQ: DS) shares tumbled 20% to $2.525 after the company announced a common stock offering of 20.83 million shares at $2.40 per share.
Shares of Ucommune International Ltd (NASDAQ: UK) were down 31% to $3.5250 after the company reported pricing of $20 million underwritten offering.
Shares of Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) got a boost, shooting 88% to $4.5690 after the company announced the acquisition of Quellis Biosciences.
GameStop Corp. (NYSE: GME) shares were also up, gaining 58% to $305.95 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday.
Equities Trading DOWN
Drive Shack Inc. (NASDAQ: DS) shares tumbled 22% to $2.46 after the company announced a common stock offering of 20.83 million shares at $2.40 per share.
Shares of Ucommune International Ltd (NASDAQ: UK) were down 34% to $3.3750 after the company reported pricing of $20 million underwritten offering.
Ted Hibben joins Vaxess as Chief Business Officer
Share Article
Vaxess Logo
As Vaxess moves the first program into the clinic, we’re excited to work with Ted to expand the pipeline into a broad range of prophylactic and therapeutic programs in infectious diseases, oncology and beyond. CAMBRIDGE, Mass. (PRWEB) January 29, 2021 Vaxess Technologies, a preclinical biotechnology company developing vaccines for both COVID and seasonal flu based on Vaxess’s proprietary MIMIXTM smart release patch, has recently appointed Mr. Ted Hibben to the position of Chief Business Officer. Mr. Hibben will be responsible for business development and corporate strategy at Vaxess, as the lead MIMIX platform program advances this year towards a Phase 1 proof-of-concept trial.